Ontology highlight
ABSTRACT: Background
Anticoagulation therapy is the mainstay of therapy for patients with venous thromboembolism (VTE). However, continuing or stopping anticoagulants after the first 3 to 6 months is a difficult decision that requires ascertainment of the risk of bleeding and recurrent VTE. Despite the development of several statistical models to predict bleeding, the benefit of machine learning (ML) models has not been investigated in depth.Objectives
To assess the benefits of ML algorithms in bleeding risk evaluation in VTE patients and gain insight into their baseline information.Methods
The baseline clinical, demographic, and genotype information was collected for 2542 patients with VTE who were on extended anticoagulation therapy. Six unsupervised dimensionality reductio
SUBMITTER: Fard SS
PROVIDER: S-EPMC11066547 | biostudies-literature | 2024 Mar
REPOSITORIES: biostudies-literature